A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism

clinical trial
rdfs:label "A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism"@en
schema:description
"clinical trial"@en
schema:dateModified "2026-03-31T15:32:16+00:00"^^xsd:dateTime
schema:version 2476734513
wikibase:identifiers 1
wikibase:sitelinks 0
wikibase:statements 15
p:P1132 wd:statement/Q63322270-55A67366-DDA9-4802-AD90-54DF37653C69
p:P2899 wd:statement/Q63322270-C09C27EF-9A32-43D2-986F-65565282DAD8
p:P3098 wd:statement/Q63322270-6008276E-BDCD-4563-AD98-A9AAC0054E5C
p:P31 wd:statement/Q63322270-ECEBBDEC-6599-4C88-84DA-1467943C9A9E
p:P4135 wd:statement/Q63322270-8047E8F0-8D20-491A-9BBD-3427E0FB1483
p:P4844 wd:statement/Q63322270-677096E8-DCF3-4888-8EAC-04BF3AAAF6F6
wd:statement/Q63322270-6B61808C-1D01-4EC9-8F4D-11747FB191A1
wd:statement/Q63322270-B120CFB7-C1CE-4122-A40D-6B32472B464D
p:P580 wd:statement/Q63322270-06290B37-C228-438E-B8C7-A1F3FCFFD761
p:P582 wd:statement/Q63322270-C43C0243-3B3A-447A-BF63-9CBDBA6E37F2
p:P6099 wd:statement/Q63322270-DF240A2A-A27D-452C-84FB-59130EE5F20D
p:P6153 wd:statement/Q63322270-80BD00D9-635A-4065-8AED-89669D5F2917
p:P8363 wd:statement/Q63322270-F44BEFC4-8635-4354-A349-77800E4431E4
p:P921 wd:statement/Q63322270-31F95635-2D6F-4F96-A2A0-EE531B294723
wd:statement/Q63322270-8256D3D6-11D6-427A-AA80-8F66E7FB81FC
wdt:P1132 200.0^^xsd:decimal
wdt:P2899 16.0^^xsd:decimal
wdt:P3098 "NCT01441804"
wdt:P31 studiu clinic
wdt:P4135 65.0^^xsd:decimal
wdt:P4844 interféron alpha
Peginterferón alfa-2a
ريبافيرين
wdt:P580 "2011-05-01T00:00:00+00:00"^^xsd:dateTime
wdt:P582 "2014-05-01T00:00:00+00:00"^^xsd:dateTime
wdt:P6099 badanie kliniczne III fazy
wdt:P6153 中山大学
wdt:P8363 Interventionsstudie
wdt:P921 التهاب كبدي
hepatitis C
Download as: